CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.960
  • 0.0000.00%
15min DelayMarket Closed May 1 16:00 ET
50.90MMarket Cap-0.91P/E (TTM)

Helix BioPharma Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
1,563.33%2M
-86.11%228K
33.79%1.08M
33.79%1.08M
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-75.15%808K
-29.33%1.33M
-Cash and cash equivalents
1,563.33%2M
-86.11%228K
33.79%1.08M
33.79%1.08M
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-75.15%808K
-29.33%1.33M
Receivables
268.75%236K
155.07%176K
-12.90%54K
-12.90%54K
-22.81%88K
-39.05%64K
-53.69%69K
-77.78%62K
-77.78%62K
-67.34%114K
-Taxes receivable
-61.22%19K
-61.11%21K
-17.02%39K
-17.02%39K
-26.26%73K
-45.56%49K
-59.70%54K
-76.85%47K
-76.85%47K
-45.60%99K
-Other receivables
1,346.67%217K
933.33%155K
0.00%15K
0.00%15K
0.00%15K
0.00%15K
0.00%15K
-80.26%15K
-80.26%15K
-91.02%15K
Prepaid assets
----
----
154.76%321K
154.76%321K
192.52%313K
-46.72%122K
-43.31%144K
-23.17%126K
-23.17%126K
62.12%107K
Total current assets
629.41%2.23M
-78.21%404K
46.18%1.46M
46.18%1.46M
-28.37%1.11M
-90.31%306K
-61.07%1.85M
-73.04%996K
-73.04%996K
-32.48%1.55M
Non current assets
Net PPE
-73.68%10K
-75.61%10K
0.00%33K
0.00%33K
-5.56%34K
-2.56%38K
7.89%41K
-5.71%33K
-5.71%33K
-2.70%36K
-Gross PPE
-32.39%1.24M
--1.34M
0.77%1.84M
0.77%1.84M
0.71%1.84M
0.71%1.84M
----
0.55%1.82M
0.55%1.82M
0.61%1.82M
-Accumulated depreciation
31.52%-1.23M
---1.33M
-0.78%-1.81M
-0.78%-1.81M
-0.84%-1.8M
-0.78%-1.8M
----
-0.67%-1.79M
-0.67%-1.79M
-0.68%-1.79M
Total non current assets
-73.68%10K
-75.61%10K
0.00%33K
0.00%33K
-5.56%34K
-2.56%38K
5.13%41K
-5.71%33K
-5.71%33K
-2.70%36K
Total assets
551.74%2.24M
-78.15%414K
44.70%1.49M
44.70%1.49M
-27.85%1.15M
-89.24%344K
-60.53%1.9M
-72.42%1.03M
-72.42%1.03M
-32.03%1.59M
Liabilities
Current liabilities
Payables
138.81%1.44M
-22.39%988K
73.43%855K
73.43%855K
178.77%1.09M
-14.71%603K
92.88%1.27M
-17.70%493K
-17.70%493K
-57.82%391K
-accounts payable
138.81%1.44M
-22.39%988K
73.43%855K
73.43%855K
178.77%1.09M
-14.71%603K
92.88%1.27M
-17.70%493K
-17.70%493K
-57.82%391K
Current accrued expenses
--821K
--790K
89.03%724K
89.03%724K
28.98%365K
----
----
11.01%383K
11.01%383K
-37.11%283K
Other current liabilities
----
----
----
----
--50K
----
----
--998K
--998K
----
Current liabilities
274.96%2.26M
39.67%1.78M
-15.74%1.58M
-15.74%1.58M
123.29%1.51M
-38.03%603K
-77.53%1.27M
-45.08%1.87M
-45.08%1.87M
-79.65%674K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
274.96%2.26M
39.67%1.78M
-15.74%1.58M
-15.74%1.58M
123.29%1.51M
-38.03%603K
-77.53%1.27M
-45.08%1.87M
-45.08%1.87M
-84.17%674K
Shareholders'equity
Share capital
4.20%161.26M
2.47%158.57M
4.28%158.57M
4.28%158.57M
2.90%156.48M
1.77%154.75M
4.62%154.75M
3.09%152.07M
3.09%152.07M
5.66%152.07M
-common stock
4.20%161.26M
2.47%158.57M
4.28%158.57M
4.28%158.57M
2.90%156.48M
1.77%154.75M
4.62%154.75M
3.09%152.07M
3.09%152.07M
5.66%152.07M
Additional paid-in capital
2.75%47.33M
4.50%46.83M
7.30%47.36M
7.30%47.36M
11.41%46.56M
14.70%46.07M
16.20%44.81M
17.42%44.14M
17.42%44.14M
39.32%41.79M
Retained earnings
-4.82%-213.38M
-4.61%-212.01M
-4.60%-210.67M
-4.60%-210.67M
-3.08%-205.39M
-2.86%-203.56M
-3.02%-202.66M
-3.22%-201.41M
-3.22%-201.41M
-2.85%-199.25M
Other equity interest
92.07%4.77M
40.98%5.24M
6.70%4.65M
6.70%4.65M
-68.31%2M
-68.56%2.49M
-60.35%3.72M
-57.84%4.36M
-57.84%4.36M
-64.73%6.31M
Total stockholders'equity
92.66%-19K
-319.29%-1.36M
89.35%-90K
89.35%-90K
-139.43%-360K
-111.65%-259K
171.91%622K
-364.89%-845K
-364.89%-845K
147.45%913K
Total equity
92.66%-19K
-319.29%-1.36M
89.35%-90K
89.35%-90K
-139.43%-360K
-111.65%-259K
171.91%622K
-364.89%-845K
-364.89%-845K
147.45%913K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 1,563.33%2M-86.11%228K33.79%1.08M33.79%1.08M-46.62%710K-95.75%120K-62.68%1.64M-75.15%808K-75.15%808K-29.33%1.33M
-Cash and cash equivalents 1,563.33%2M-86.11%228K33.79%1.08M33.79%1.08M-46.62%710K-95.75%120K-62.68%1.64M-75.15%808K-75.15%808K-29.33%1.33M
Receivables 268.75%236K155.07%176K-12.90%54K-12.90%54K-22.81%88K-39.05%64K-53.69%69K-77.78%62K-77.78%62K-67.34%114K
-Taxes receivable -61.22%19K-61.11%21K-17.02%39K-17.02%39K-26.26%73K-45.56%49K-59.70%54K-76.85%47K-76.85%47K-45.60%99K
-Other receivables 1,346.67%217K933.33%155K0.00%15K0.00%15K0.00%15K0.00%15K0.00%15K-80.26%15K-80.26%15K-91.02%15K
Prepaid assets --------154.76%321K154.76%321K192.52%313K-46.72%122K-43.31%144K-23.17%126K-23.17%126K62.12%107K
Total current assets 629.41%2.23M-78.21%404K46.18%1.46M46.18%1.46M-28.37%1.11M-90.31%306K-61.07%1.85M-73.04%996K-73.04%996K-32.48%1.55M
Non current assets
Net PPE -73.68%10K-75.61%10K0.00%33K0.00%33K-5.56%34K-2.56%38K7.89%41K-5.71%33K-5.71%33K-2.70%36K
-Gross PPE -32.39%1.24M--1.34M0.77%1.84M0.77%1.84M0.71%1.84M0.71%1.84M----0.55%1.82M0.55%1.82M0.61%1.82M
-Accumulated depreciation 31.52%-1.23M---1.33M-0.78%-1.81M-0.78%-1.81M-0.84%-1.8M-0.78%-1.8M-----0.67%-1.79M-0.67%-1.79M-0.68%-1.79M
Total non current assets -73.68%10K-75.61%10K0.00%33K0.00%33K-5.56%34K-2.56%38K5.13%41K-5.71%33K-5.71%33K-2.70%36K
Total assets 551.74%2.24M-78.15%414K44.70%1.49M44.70%1.49M-27.85%1.15M-89.24%344K-60.53%1.9M-72.42%1.03M-72.42%1.03M-32.03%1.59M
Liabilities
Current liabilities
Payables 138.81%1.44M-22.39%988K73.43%855K73.43%855K178.77%1.09M-14.71%603K92.88%1.27M-17.70%493K-17.70%493K-57.82%391K
-accounts payable 138.81%1.44M-22.39%988K73.43%855K73.43%855K178.77%1.09M-14.71%603K92.88%1.27M-17.70%493K-17.70%493K-57.82%391K
Current accrued expenses --821K--790K89.03%724K89.03%724K28.98%365K--------11.01%383K11.01%383K-37.11%283K
Other current liabilities ------------------50K----------998K--998K----
Current liabilities 274.96%2.26M39.67%1.78M-15.74%1.58M-15.74%1.58M123.29%1.51M-38.03%603K-77.53%1.27M-45.08%1.87M-45.08%1.87M-79.65%674K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 274.96%2.26M39.67%1.78M-15.74%1.58M-15.74%1.58M123.29%1.51M-38.03%603K-77.53%1.27M-45.08%1.87M-45.08%1.87M-84.17%674K
Shareholders'equity
Share capital 4.20%161.26M2.47%158.57M4.28%158.57M4.28%158.57M2.90%156.48M1.77%154.75M4.62%154.75M3.09%152.07M3.09%152.07M5.66%152.07M
-common stock 4.20%161.26M2.47%158.57M4.28%158.57M4.28%158.57M2.90%156.48M1.77%154.75M4.62%154.75M3.09%152.07M3.09%152.07M5.66%152.07M
Additional paid-in capital 2.75%47.33M4.50%46.83M7.30%47.36M7.30%47.36M11.41%46.56M14.70%46.07M16.20%44.81M17.42%44.14M17.42%44.14M39.32%41.79M
Retained earnings -4.82%-213.38M-4.61%-212.01M-4.60%-210.67M-4.60%-210.67M-3.08%-205.39M-2.86%-203.56M-3.02%-202.66M-3.22%-201.41M-3.22%-201.41M-2.85%-199.25M
Other equity interest 92.07%4.77M40.98%5.24M6.70%4.65M6.70%4.65M-68.31%2M-68.56%2.49M-60.35%3.72M-57.84%4.36M-57.84%4.36M-64.73%6.31M
Total stockholders'equity 92.66%-19K-319.29%-1.36M89.35%-90K89.35%-90K-139.43%-360K-111.65%-259K171.91%622K-364.89%-845K-364.89%-845K147.45%913K
Total equity 92.66%-19K-319.29%-1.36M89.35%-90K89.35%-90K-139.43%-360K-111.65%-259K171.91%622K-364.89%-845K-364.89%-845K147.45%913K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.